Skip to main content

Table 2 Main features of the studies

From: Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis

Studies

Type of study

Methodological quality grading

No of patients with thrombocytopenia at baseline (n)

No of patients in the control group (n)

Average PLT count in the study group

Ayoub 2018 [8]

OS

B

32, 565

32, 565

< 150,000 cells/μl

Ito 2018 [9]

OS

B

2298

16, 763

100–150,000 cells/μl

Kiviniemi 2013 [10]

OS

B

99

762

80–150,000 cells/μl

Liu 2018 [11]

OS

B

1263

8634

50–150,000 cells/μl

Overgaard 2008 [12]

OS

B

639

10,182

< 150,000 cells/μl

Raphael 2016 [13]

OS

B

146

1281

≤ 100,000 cells/μl

Shiraishi 2019 [14]

OS

B

226

1009

50,000–149,000 cells/μL

Yadav 2016 [15]

RCT

B

607

9996

< 150,000 cells/μl

Total number of participants (n)

  

37,753

81,192

 
  1. Abbreviations: PLT platelet, OS observational study, RCT randomized controlled trials